--(BUSINESS WIRE)--Cadrenal Therapeutics, Inc. (Nasdaq ... and provided a business update and highlights of the path forward for the clinical advancement of tecarfarin. “2024 for Cadrenal was a year ...

Kate is wearing a striking Catherine Walker dress and a matching hat by Gina Foster—a very similar hue to the deputy Labour leader, who also chose to wear bright red. She's wearing her long ...

SEOUL, South Korea--(BUSINESS WIRE)--Hudson Therapeutics, the U.S. subsidiary of Shaperon, announced today that Shaperon will commence the Phase 2b Part 2 of its clinical trial for NuGel ...

It’s a major milestone for the Princess of Wales: Today marks Kate Middleton’s official return to Commonwealth Day after missing the 2024 occasion due to her cancer diagnosis, which she revealed to ...

The clinical trials will be performed in three different countries, Italy, Australia and Germany. Part of the investment round will be invested in Italy and allocated to the activities of the newly ...

As chairman of the Senate Armed Services Committee, the Hon. Roger Wicker holds the gavel of SASC’s 27-member committee and its seven subcommittees: Airland; Cybersecurity; Emerging Threats and ...

Centauri Therapeutics Limited has announced the selection of its first clinical candidate for the ABX-01 programme. The compound is designed to target serious Gram-negative bacterial lung infections.

Leaning on the company’s other pipeline drugs, a Pliant Therapeutics spokesperson said: “Pliant is committed to the development of its other clinical and pipeline assets, including PLN-101095 in ...

we believe that Callio Therapeutics will be the first company to show the clinical benefit of this exciting new multi-payload ADC approach and is well positioned to transform cancer therapy.” About ...

MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today reported financial results for the fourth quarter and ...